VanEck Biotech ETF
BBH
83 hedge funds and large institutions have $73M invested in VanEck Biotech ETF in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 14 closing their positions.
8% more capital invested
Capital invested by funds: $67.4M → $73M (+$5.6M)
4.56% more ownership
Funds ownership: 18.22% → 22.78% (+4.6%)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
5% less funds holding
Funds holding: 87 → 83 (-4)
39% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 23
70% less call options, than puts
Call options by funds: $257K | Put options by funds: $845K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$6.73M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4.44M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.59M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.97M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$2.81M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.1M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$705K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$564K |
| 5 |
Bank of New York Mellon
New York
|
-$426K |
BBH Hedge Fund Activity: Q1 2020 in Review
83 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2020, worth a combined $73M — up 8.3% from $67.4M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of BBH and 13 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 14 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $6.73M. The largest seller was Jane Street, exiting entirely with an estimated $2.81M sold.
- 83 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2020, down from 87 in Q4 2019.
- Funds reported $73M of VanEck Biotech ETF stock for Q1 2020, up 8.3% quarter-over-quarter.
- 13 funds opened new VanEck Biotech ETF positions in Q1 2020 and 14 closed out, a net change of -1 holder.
- The largest VanEck Biotech ETF buyer in Q1 2020 was Goldman Sachs, an estimated $6.73M added.
- The largest VanEck Biotech ETF seller in Q1 2020 was Jane Street, an estimated $2.81M sold.
Based on aggregated 13F filings for Q1 2020.